Share on LinkedInShare on LinkedIn

ARTICLE · 30 JULY 2026

Standing And Preemption Deliver Early Dismissals In Toothpaste Heavy Metals Class Action

Dechert
Dechert
Contributor
Dechert

Dechert

Dechert helps business leaders lead For more than 150 years, we’ve advised the innovators who move...

View firm profile
Explore more from Dechert

Brower reinforces two strong early defenses against class actions targeting OTC product labeling and marketing. First, plaintiffs alleging product contamination must plead product-specific testing...

United StatesLitigation, Mediation & Arbitration

Key Takeaways

Brower reinforces two strong early defenses against class actions targeting OTC product labeling and marketing. First, plaintiffs alleging product contamination must plead product-specific testing linked to their own purchases; generalized testing or studies will not suffice. Second, omission-based claims are expressly preempted where the FDA’s governing monograph does not require the disclosure plaintiffs seek.

Brower extends to heavy metals claims against Colgate toothpastes the same reasoning we previously wrote about in PFAS consumer class actions, and pairs it with an express preemption ruling rejecting omission-based claims. Brower v. Colgate-Palmolive Co., 2026 WL 1831253 (S.D.N.Y. June 25, 2026). The decision provides additional authority for early dismissal of similar claims targeting FDA-regulated over-the-counter (“OTC”) products.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from